In the eyes of the United States, Canada has a drug problem.

Granted, this isn’t an illegal narcotics or drug cartel problem. But in the world of international trade, the problem is pretty bad. In fact, it’s serious enough to land Canada on the “Watch List” in the U.S. Trade Representative’s “Special 301 Report”—a report released annually that evaluates the intellectual property rights protection and enforcement of the United States’s trading partners.